6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol

C41H44Br2N4O2 — CID 157128391

IUPAC6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol
SMILESCOc1cc(C)cc2c1C(=C1CCNCC1)c1ncc(Br)cc1CC2.Cc1cc(O)c2c(c1)CCc1cc(Br)cnc1C2=C1CCNCC1
InChIInChI=1S/C21H23BrN2O.C20H21BrN2O/c1-13-9-15-3-4-16-11-17(22)12-24-21(16)20(14-5-7-23-8-6-14)19(15)18(10-13)25-2;1-12-8-14-2-3-15-10-16(21)11-23-20(15)19(18(14)17(24)9-12)13-4-6-22-7-5-13/h9-12,23H,3-8H2,1-2H3;8-11,22,24H,2-7H2,1H3
InChIKeyAITQRUOWHRXRFX-UHFFFAOYSA-N
MW784.64 g/mol
LogP8.59
Rot. Bonds1

About 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol

6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol (PubChem CID 157128391) has the molecular formula C41H44Br2N4O2 and a molecular weight of 784.64 g/mol. Its IUPAC name is 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol.

Molecular Properties

Compound Name6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol
PubChem CID157128391
Molecular FormulaC41H44Br2N4O2
Molecular Weight784.64 g/mol
Exact Mass782.18
IUPAC Name6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol
SMILESCOc1cc(C)cc2c1C(=C1CCNCC1)c1ncc(Br)cc1CC2.Cc1cc(O)c2c(c1)CCc1cc(Br)cnc1C2=C1CCNCC1
InChIInChI=1S/C21H23BrN2O.C20H21BrN2O/c1-13-9-15-3-4-16-11-17(22)12-24-21(16)20(14-5-7-23-8-6-14)19(15)18(10-13)25-2;1-12-8-14-2-3-15-10-16(21)11-23-20(15)19(18(14)17(24)9-12)13-4-6-22-7-5-13/h9-12,23H,3-8H2,1-2H3;8-11,22,24H,2-7H2,1H3
InChIKeyAITQRUOWHRXRFX-UHFFFAOYSA-N
XLogP8.59
TPSA79.30 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds1
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500784.64
LogP ≤ 58.59
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol?
The IUPAC name of 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol (CID 157128391) is 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol.
What is the SMILES notation for 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol?
The canonical SMILES for 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol is COc1cc(C)cc2c1C(=C1CCNCC1)c1ncc(Br)cc1CC2.Cc1cc(O)c2c(c1)CCc1cc(Br)cnc1C2=C1CCNCC1.
What is the InChIKey of 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol?
The InChIKey is AITQRUOWHRXRFX-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H23BrN2O.C20H21BrN2O/c1-13-9-15-3-4-16-11-17(22)12-24-21(16)20(14-5-7-23-8-6-14)19(15)18(10-13)25-2;1-12-8-14-2-3-15-10-16(21)11-23-20(15)19(18(14)17(24)9-12)13-4-6-22-7-5-13/h9-12,23H,3-8H2,1-2H3;8-11,22,24H,2-7H2,1H3.
What are the key properties of 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol?
6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol has a molecular weight of 784.64 g/mol, XLogP of 8.59, 1 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-15-methoxy-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene;6-bromo-13-methyl-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-15-ol is sourced from PubChem (CID 157128391), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).